Estrella Immunopharma, Inc.

US$0.38As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ESLAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (47.32%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.89
PE TTM —
TSR TTM (84.49%)
Mkt cap US$16.32M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.486
29.42%
151.24%
Hold 9|1|6|10|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
33.64%
29.97%
25.76%
19.92%
Revenue$M
0.794
0.771
0.783
0.794
2.08%
0.48%
(2.57%)
(1.13%)
Peers (US$16.32M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.933
0.044
0.038
EBIT/Intx
0.175
0.146
0.157
Own earn%
187.69
(1.31)
11.74
Sh yield%
34.24
26.67
27.54
Owners
Insiders/Inst%
4.91
81.16
Short interest%
3.16
SBC / revenue%
4.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
18